VascularStrategies
Plymouth Meeting, PA, United States vascularstrategy.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
VascularStrategies is a contract research organization that supports pharmaceutical and biotech companies with preclinical and Phase I-IV drug development studies. It provides in vitro and in vivo research services focused on cardiovascular disease, lipoprotein function, HDL, reverse cholesterol transport, and atherosclerosis. The company is based in Plymouth Meeting, Pennsylvania.
VascularStrategies is a CRO in Plymouth Meeting, PA, founded in 2008. It lists 15 services, including ABCA1 cellular cholesterol efflux, Global cellular cholesterol efflux and SR-BI cellular cholesterol efflux. It names GLP and GMP on its listing.
Services
ABCA1 cellular cholesterol efflux
Measures cellular cholesterol efflux through ABCA1 in vitro.
Global cellular cholesterol efflux
Assesses overall cellular cholesterol efflux in vitro.
SR-BI cellular cholesterol efflux
Measures SR-BI-mediated cellular cholesterol efflux in vitro.
Ex Vivo LCAT activity
Assesses LCAT activity using ex vivo methods.
SR-BI mediated cellular cholesterol uptake
Measures cholesterol uptake mediated by SR-BI.
Cell-free HDL Inflammatory Index (HII)
Evaluates HDL inflammatory index in a cell-free assay format.
Reverse Cholesterol Transport (RCT)
Performs preclinical in vivo assessment of reverse cholesterol transport in rodent models.
Lipoprotein Clearance
Assesses clearance of HDL, LDL, and VLDL in vivo.
7 more services
- Atherosclerosis lesion progression and regression
- Human Aortic Endothelial Cell cytokine / adhesion molecule expression assays
- Macrophage cytokine and adhesion molecule expression
- Serum Lipid and Lipoprotein quantitation
- Lipid transfer proteins (CETP, PLTP)
- Lipase activity assays (EL, HL, LPL)
- Serum Apoprotein ELISAs
How to order from VascularStrategies
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- In vivo
- Rodent models
- Cell-free expression
- ABCA1 cellular cholesterol efflux
- Global cellular cholesterol efflux
- SR-BI cellular cholesterol efflux
11 more
- Ex Vivo LCAT activity
- SR-BI mediated cellular cholesterol uptake
- Cell-free HDL Inflammatory Index (HII)
- Reverse Cholesterol Transport (RCT)
- Lipoprotein Clearance
- Atherosclerosis lesion progression and regression
- Cytokine / adhesion molecule expression assays
- Serum Lipid and Lipoprotein quantitation
- Lipid transfer proteins
- Lipase activity assays
- Serum Apoprotein ELISAs
- Scale and capacity
- Over 8,000 sq. ft. of space
- Therapeutic areas
- Cardiovascular disease
- Lipid disorders
- Lipoprotein disorders
- Metabolic disorders
- HDL function
- Inflammatory markers
- CAD
- Atherosclerosis
Modalities and species
- Modalities
- Small molecule
- Species and models
- Rodent models of atherosclerosis
- Human aortic endothelial cells
- Macrophages
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
GMPSelf-reported
Details
- Type
- CRO
- Founded
- 2008
- Address
- 5110 Campus Drive, Suite 137 Plymouth Meeting, PA 19462
- Serves
- Pharmaceutical companies, biotech companies, academic partners, CRO partners